“A unique design feature of this promising technology is the ability to modify the fill volume of the Mitra-Spacer System post-procedure. This allows adjusting the mitral regurgitation therapy to the capacity of the left heart function and to eliminate residual mitral regurgitation in the long term course after implant”,
-Professor Olaf Wendler - Kings College, London UK
New Concept to treat Functional Mitral Regurgitation using an Adjustable Spacer
Thomas Piemonte, M.D., FACC, Chief Medical Officer. Dr. Piemonte is the Director,Interventional Cardiovascular Medicine and Cardiac Catheterization Laboratory at the Lahey Clinic in Burlington, Massachusetts. Dr. Piemonte is a graduate of The College of the Holy Cross and New York Medical College. He was an intern, resident and Chief Resident at St. Elizabeth’s Hospital in Boston, Massachusetts.
Michael is active in private equity investing as an angel investor, board member, mentor, technical adviser and strategic partner. Michael served or serves on the board of Mtuitive, Spirus Medical, Cardiosolutions and AngioLink. He also helped found and chair Bay Angels, LLC, an angel group focused on seed level investment. Michael was the founder and CEO of Vista High-Tech Resources, Inc., and was at the helm of the company for 15 years before it was sold to Compuware in 1999